Gene editing Market Research Report Information By Technology (CRISPR, TALEN, ZFN, Antisense, and others), Application (Genetic Engineering, Gene Therapy, Cell Line Engineering, and Others), End User (Biotechnology and Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes ) and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2032.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING FUNDING FOR GENETIC RESEARCH

4.2.2 RISING INCIDENCE OF GENETIC DISORDERS

4.2.3 GROWING NUMBER OF STRATEGIC INITIATIVES

4.3 RESTRAINTS

4.3.1 OFF-TARGET EFFECTS OF CRISPR TECHNOLOGY

4.3.2 HIGH COST OF EQUIPMENT

4.4 OPPORTUNITIES

4.4.1 INCREASING APPLICATION AREAS OF GENE EDITING

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL GENE EDITING MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON REGIONS

5.3.3 IMPACT ON SUPPLY GAP ANALYSIS

5.3.4 IMPACT ON PRICING

6 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY

6.1 OVERVIEW

6.2 CRISPR

6.3 TALEN

6.4 ZFN

6.5 ANTISENSE

6.6 OTHERS

7 GLOBAL GENE EDITING MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 GENETIC ENGINEERING

7.3 GENE THERAPY

7.4 CELL LINE ENGINEERING

7.5 OTHERS

8 GLOBAL GENE EDITING MARKET, BY END USER

8.1 OVERVIEW

8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

8.3 CONTRACT RESEARCH ORGANIZATIONS

8.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

9 GLOBAL GENE EDITING MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 UK

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 JAPAN

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL GENE EDITING MARKET

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL GENE EDITING MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT EXPANSION AND LAUNCH

10.6.2 AGREEMENT/COLLABORATION

10.7 FINANCIAL MATRIX

10.7.1 SALES (USD MILLION), 2021

10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES

11.1 BIO-RAD LABORATORIES, INC

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 GE HEALTHCARE

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 GENSCRIPT

11.3.1 COMPANY OVERVIEWS

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 INTEGRATED DNA TECHNOLOGIES, INC

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 NEW ENGLAND BIOLABS

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 KEY STRATEGIES

11.6 SANGAMO THERAPEUTICS

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.6.6 KEY STRATEGIES

11.7 THERMO FISHER SCIENTIFIC, INC

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.7.6 KEY STRATEGIES

11.8 LONZA

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 KEY STRATEGIES

11.9 HORIZON DISCOVERY LTD

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 ORIGENE TECHNOLOGIES, INC

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20

TABLE 3 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 36

TABLE 4 GLOBAL GENE EDITING MARKET, FOR CRISPR, BY REGION, 2019–2030 (USD MILLION) 36

TABLE 5 GLOBAL GENE EDITING MARKET, FOR TALEN, BY REGION, 2019–2030 (USD MILLION) 37

TABLE 6 GLOBAL GENE EDITING MARKET, FOR ZFN, BY REGION, 2019–2030 (USD MILLION) 37

TABLE 7 GLOBAL GENE EDITING MARKET, FOR ANTISENSE, BY REGION, 2019–2030 (USD MILLION) 37

TABLE 8 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD MILLION) 38

TABLE 9 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 41

TABLE 10 GLOBAL GENE EDITING MARKET, FOR GENETIC ENGINEERING, BY REGION, 2019–2030 (USD MILLION) 41

TABLE 11 GLOBAL GENE EDITING MARKET, FOR GENE THERAPY, BY REGION, 2019–2030 (USD MILLION) 42

TABLE 12 GLOBAL GENE EDITING MARKET, FOR CELL LINE ENGINEERING, BY REGION, 2019–2030 (USD MILLION) 42

TABLE 13 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD MILLION) 42

TABLE 14 GLOBAL GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 45

TABLE 15 GLOBAL GENE EDITING MARKET, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2019–2030 (USD MILLION) 45

TABLE 16 GLOBAL GENE EDITING MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2030 (USD MILLION) 46

TABLE 17 GLOBAL GENE EDITING MARKET, FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2030 (USD MILLION) 46

TABLE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2019–2030 (USD MILLION) 47

TABLE 19 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2019–2030 (USD MILLION) 50

TABLE 20 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 51

TABLE 21 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 51

TABLE 22 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 51

TABLE 23 US: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 52

TABLE 24 US: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 52

TABLE 25 US: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 52

TABLE 26 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 53

TABLE 27 CANADA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 53

TABLE 28 CANADA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 53

TABLE 29 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2019–2030 (USD MILLION) 55

TABLE 30 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 56

TABLE 31 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 56

TABLE 32 EUROPE: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 57

TABLE 33 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 57

TABLE 34 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 58

TABLE 35 GERMANY: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 58

TABLE 36 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 58

TABLE 37 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 59

TABLE 38 FRANCE: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 59

TABLE 39 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 59

TABLE 40 UK: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 60

TABLE 41 UK: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 60

TABLE 42 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 60

TABLE 43 ITALY: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 61

TABLE 44 ITALY: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 61

TABLE 45 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 61

TABLE 46 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 62

TABLE 47 SPAIN: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 62

TABLE 48 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 62

TABLE 49 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 63

TABLE 50 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 63

TABLE 51 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2019–2030 (USD MILLION) 65

TABLE 52 ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 65

TABLE 53 ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 66

TABLE 54 ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 66

TABLE 55 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 67

TABLE 56 CHINA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 67

TABLE 57 CHINA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 68

TABLE 58 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 68

TABLE 59 INDIA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 68

TABLE 60 INDIA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 69

TABLE 61 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 69

TABLE 62 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 70

TABLE 63 JAPAN: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 70

TABLE 64 AUSTRALIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 71

TABLE 65 AUSTRALIA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 71

TABLE 66 AUSTRALIA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 71

TABLE 67 SOUTH KOREA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 72

TABLE 68 SOUTH KOREA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 72

TABLE 69 SOUTH KOREA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 72

TABLE 70 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 73

TABLE 71 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 73

TABLE 72 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 73

TABLE 73 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2019–2030 (USD MILLION) 75

TABLE 74 REST OF THE WORLD: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 75

TABLE 75 REST OF THE WORLD: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 76

TABLE 76 REST OF THE WORLD: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 76

TABLE 77 MIDDLE EAST: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 77

TABLE 78 MIDDLE EAST: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 77

TABLE 79 MIDDLE EAST: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 77

TABLE 80 AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 78

TABLE 81 AFRICA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 78

TABLE 82 AFRICA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 78

TABLE 83 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019–2030 (USD MILLION) 79

TABLE 84 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 79

TABLE 85 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2019–2030 (USD MILLION) 79

TABLE 86 MAJOR PLAYERS IN THE GLOBAL GENE EDITING MARKET 80

TABLE 87 MOST ACTIVE PLAYER IN THE GLOBAL GENE EDITING MARKET 82

TABLE 88 PRODUCT EXPANSION AND LAUNCH: GLOBAL GENE EDITING MARKET 83

TABLE 89 AGREEMENT/COLLABORATION: GLOBAL GENE EDITING MARKET 84

TABLE 90 BIO-RAD LABORATORIES, INC: PRODUCTS OFFERED 87

TABLE 91 GE HEALTHCARE: PRODUCTS OFFERED 90

TABLE 92 GENSCRIPT: PRODUCTS OFFERED 93

TABLE 93 GENSCRIPT: KEY DEVELOPMENTS 93

TABLE 94 INTEGRATED DNA TECHNOLOGIES, INC: PRODUCTS OFFERED 95

TABLE 95 INTEGRATED DNA TECHNOLOGIES, INC: KEY DEVELOPMENTS 96

TABLE 96 NEW ENGLAND BIOLABS: PRODUCTS OFFERED 97

TABLE 97 SANGAMO THERAPEUTICS: PRODUCTS OFFERED 100

TABLE 98 SANGAMO THERAPEUTICS: KEY DEVELOPMENTS 100

TABLE 99 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 103

TABLE 100 LONZA: PRODUCTS OFFERED 106

TABLE 101 LONZA: KEY DEVELOPMENTS 106

TABLE 102 HORIZON DISCOVERY LTD: PRODUCTS OFFERED 107

TABLE 103 HORIZON DISCOVERY LTD: KEY DEVELOPMENTS 107

TABLE 104 ORIGENE TECHNOLOGIES, INC: PRODUCTS OFFERED 109

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 15

FIGURE 2 GLOBAL GENE EDITING MARKET 16

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL GENE EDITING MARKET 25

FIGURE 5 DRIVER IMPACT ANALYSIS 27

FIGURE 6 RESTRAINT IMPACT ANALYSIS 28

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL GENE EDITING MARKET 29

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL GENE EDITING MARKET 31

FIGURE 9 GLOBAL GENE EDITING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, (USD MILLION) 35

FIGURE 10 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2022 & 2030 (USD MILLION) 35

FIGURE 11 GLOBAL GENE EDITING MARKET SHARE (%), BY TECHNOLOGY, 2022 36

FIGURE 12 GLOBAL GENE EDITING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, (USD MILLION) 40

FIGURE 13 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 40

FIGURE 14 GLOBAL GENE EDITING MARKET SHARE (%), BY APPLICATION, 2022 41

FIGURE 15 GLOBAL GENE EDITING MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION) 43

FIGURE 16 GLOBAL GENE EDITING MARKET, BY END USER, 2022 & 2030 (USD MILLION) 44

FIGURE 17 GLOBAL GENE EDITING MARKET SHARE (%), BY END USER, 2022 45

FIGURE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 47

FIGURE 19 GLOBAL GENE EDITING MARKET SHARE (%), BY REGION, 2022 48

FIGURE 20 NORTH AMERICA MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 49

FIGURE 21 NORTH AMERICA: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 50

FIGURE 22 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 50

FIGURE 23 EUROPE MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 54

FIGURE 24 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 55

FIGURE 25 EUROPE: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 56

FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 64

FIGURE 27 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 64

FIGURE 28 ASIA-PACIFIC: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 65

FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 74

FIGURE 30 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 74

FIGURE 31 REST OF THE WORLD: GENE EDITING MARKET SHARE (%), BY REGION, 2022 75

FIGURE 32 BENCHMARKING OF MAJOR COMPETITORS 81

FIGURE 33 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL GENE EDITING MARKET 82

FIGURE 34 GLOBAL GENE EDITING MARKET: COMPETITIVE LANDSCAPE 83

FIGURE 35 SALES 2021 84

FIGURE 36 RESEARCH & DEVELOPMENT EXPENDITURE, 2021 85

FIGURE 37 BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT 87

FIGURE 38 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS 88

FIGURE 39 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 90

FIGURE 40 GE HEALTHCARE: SWOT ANALYSIS 91

FIGURE 41 GENSCRIPT: FINANCIAL OVERVIEW SNAPSHOT 92

FIGURE 42 GENSCRIPT: SWOT ANALYSIS 94

FIGURE 43 SANGAMO THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT 99

FIGURE 44 SANGAMO THERAPEUTICS: SWOT ANALYSIS 101

FIGURE 45 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 103

FIGURE 46 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 104

FIGURE 47 LONZA: FINANCIAL OVERVIEW SNAPSHOT 105